Four IPOs each raised at least $75 million this week as the Fall IPO market continued to hum along, while one company ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

LATEST IPOS AND DIRECT LISTINGS ... Camp4 is a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with ...

The U.S.'s dominance in biotech innovation is critical to our national interests; yet, our government policies are ...

The US IPO market is seeing renewed momentum as the 2024 presidential election approaches, with investors and analysts eyeing ...

Ceribell rang in a $180.3 million IPO last week, with its public debut on the Nasdaq coming in well above its first pricing ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

That makes it the second-largest biotech IPO this year, after Acelyrin raised $540 million in May. The biotech is developing a radiopharmaceutical called RYZ101 in phase 3 trials for ...